Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London · Delayed Price · Currency is GBP · Price in USD 768.80
+23.18 (3.11%)
At close: Dec 19, 2025
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
696.33K GBP
Profits / Employee
223.74K GBP
Market Cap
58.91B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
| Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
| Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
| Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
| Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Regeneron Pharmaceuticals News
- 19 hours ago - Regeneron: The Turnaround Is Gaining Steam - Seeking Alpha
- 1 day ago - Alvotech, Teva Secures U.S. License Entry Date For Eylea Biosimilar AVT06 - Nasdaq
- 1 day ago - Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S. - Seeking Alpha
- 4 days ago - Regeneron Pharmaceuticals, Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma - Slideshow - Seeking Alpha
- 5 days ago - Regeneron Pharmaceuticals Inc (REGN)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
- 7 days ago - 2 Reasons to Buy Regeneron Stock Like There's No Tomorrow - The Motley Fool
- 8 days ago - Regeneron Pharmaceuticals (REGN) Receives Updated Analyst Ratings from Morgan Stanley | REGN ... - GuruFocus
- 8 days ago - Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy? - Nasdaq